CBSNews.com
/
CBS Evening News
/
CBS This Morning
/
60 Minutes
/
Sunday Morning
/
Face the Nation
/
48 Hours
Markets
Investing
Tech
Leadership
Small Business
Saving
Spending
Retirement
Video
Log In
Log In
Join CBSNews.com
Sign in with
My Profile
Manage my newsletter subscriptions
Update my e-mail address
Change my password
Log Out
Get
Recent Quotes
View Full List
/
Top Indices
Dow Jones Industrials
Nasdaq Composite
S&P 500
NYSE Composite
NYSE MKT Composite
Merck & Co., Inc.
(NY:
MRK
)
45.21
USD
-0.78 (-1.70%)
Official Closing Price
/ Updated:
6:40 PM EDT, May 20, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Options
Historical Prices
Chart
Chart
News
All News
Press Releases
Related Stories
Blogs
Podcasts
SEC Filings
Quarterly Reports
Insider Filings
Other Filings
Stories about Merck & Co., Inc.
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
UK first in EU to get Merck's new Schmallenberg vaccine
May 20, 2013
LONDON, May 21 (Reuters) - British farmers will be the first in Europe to get a vaccine against Schmallenberg virus, a new livestock disease that hit the continent in 2011.
Read More
category
companyNews
from
Reuters: Company News
Cramer's Watch List Ahead of Big Cancer Conference
May 20, 2013
The American Society of Clinical Oncology meeting scheduled to begin on May 31st could generate a cornucopia of health care catalysts, said Jim Cramer.
Read More
category
BioMarin Pharmaceutical Inc
,
Biotechnology
,
Merck & Co Inc
, and 13 more.
from
CNBC.com News
Monday's ETF with Unusual Volume: DTN
May 20, 2013
The WisdomTree Dividend ex-Financials Fund ETF (DTN) is seeing unusually high volume in afternoon trading Monday, with over 168,000 shares traded versus three month average volume of about 65,000....
Read More
category
ETFs
from
ETF Channel
50-Day SMA Crossers 05/20: (ELN) (ACI) (AAPL) Above; (MRK) (TLAB) (CLSN) Below
May 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8354836 for the full story.
Read More
from
StreetInsider.com News Articles
Merck's (MRK) Suvorexant Faces Challenges at FDA
May 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8354471 for the full story.
Read More
from
StreetInsider.com News Articles
UPDATE 3-FDA staff says Merck's sleep drug effective, questions dosage
May 20, 2013
* Reviewers say lower doses of suvorexant safer than high * Cite risk of next-day sedation, suicidal thinking * Merck shares fall 1 percent in midday trading By Toni Clarke WASHINGTON, May 20 (Reuters)...
Read More
category
companyNews
from
Reuters: Company News
More Details about Hisun-Pfizer and Merck-Simcere JVs
May 20, 2013
In 2011, the world’s two largest drugmakers – Pfizer and Merck – each announced major China drug JVs with domestic China pharmas – Hisun in Pfizer’s case and Simcere for Merck. The arrangements were...
Read More
from
ChinaBio® Today
Merck Earnings In Retrospect: Up 0.7% in the Last 19 Days (MRK)
May 20, 2013
from
Comtex SmarTrend® News Briefs
FDA staff say Merck's sleep drug effective, question dose levels
May 20, 2013
May 20 (Reuters) - *FDA STAFF REVIEWERS SAY CLINICAL TRIALS OF MERCK'S SLEEP DRUG SUVOREXANT "OVERALL, ESTABLISH EFFECTIVENESS." *FDA STAFF REVIEWERS SAY SUVOREXANT SEEMS TO BE ASSOCIATED WITH EVENTS...
Read More
category
companyNews
from
Reuters: Company News
Jennifer Aniston: Movie Star Turned Hair Care Mogul
May 17, 2013
After trying its products this Hollywood star bought an equity stake in the company. Could her endorsement lead to big profits and even an IPO?
Read More
category
Coca Cola Co
,
Investing
,
Consumer Discretionary/Retail
, and 8 more.
from
CNBC.com News
Bristol-Myers Squibb’s drug combo can shrink cancer tumors
May 16, 2013
category
Health Care
,
Roche Group
,
Food & Drug Administration
, and 4 more.
from
Business Journals
DEALTALK-Novartis' Vasella exit opens door to Roche stake sale
May 16, 2013
* Novartis' one-third stake in Roche built up under Vasella
Read More
category
companyNews
from
Reuters: Company News
Finding the Next Big Blockbuster Drug
May 15, 2013
from
ACCESSWIRE
With 'Cell Death' Drugs, Bristol-Myers May Win No Matter What
May 15, 2013
A new class of anti-cancer drugs that allow the immune system to attack cancer cells are generating considerable excitement among patients, doctors, and investors. New results being released ahead of...
Read More
category
NYSE:JNJ
,
NYSE:MRK
,
NASDAQ:PCYC
, and 2 more.
from
Forbes Real Time
Roche immunotherapy shows response over range of cancers
May 15, 2013
May 15 (Reuters) - An experimental Roche Holding AG drug that helps the immune system attack tumors was well tolerated and demonstrated an impressive effect against a variety of cancers, according to...
Read More
category
companyNews
from
Reuters: Company News
Cooperman's Omega Advisors Gets Into Gold and Silver ETFs (GLD) (GDX) (SLV) (more...)
May 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8342891 for the full story.
Read More
from
StreetInsider.com News Articles
StockCall Scrutinizes PFE, MRK, JNJ, ABBV, and ZGNX
May 15, 2013
from
ACCESSWIRE
Should I Buy Pfizer? 3 Pros, 3 Cons
May 15, 2013
Read More
category
NYSE:MRK
,
Stocks to Buy
,
NYSE:PFE
, and 3 more.
from
InvestorPlace - Latest Headlines
Market Wrap: Loeb Eyes Sony Split; Wal-mart Gets Transparent; More Bullish on Tesla
May 14, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8338522 for the full story.
Read More
from
StreetInsider.com News Articles
Merck & Co., (MRK) guaranteed senior unsec. rating to A1 from Aa3 by Moody's
May 14, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8338323 for the full story.
Read More
from
StreetInsider.com News Articles
Companies receiving the most NC tax breaks
May 14, 2013
category
Time Warner Cable
,
Target
,
Cree
, and 11 more.
from
Business Journals
OEF, IBM, MRK, ORCL: Large Outflows Detected at ETF
May 14, 2013
Symbols mentioned in this story: OEF, IBM, MRK, ORCL Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''...
Read More
category
ETFs
from
ETF Channel
Can Merck’s Pipeline Offset The Pain From Major Patent Expirations?
May 14, 2013
category
Pharmaceuticals
from
Trefis
The Conundrum Of Healthcare In India
May 14, 2013
On a daily basis, one can come across a story in the U.S. print or electronic media about the problems faced in this country around the increased number of overweight and obese Americans. These...
Read More
category
NYSE:JNJ
,
NYSE:MRK
from
Forbes Real Time
UPDATE 1-Merck KGaA steps up cost savings, boosting profit
May 14, 2013
FRANKFURT, May 14 (Reuters) - German drugs and chemicals maker Merck KGaA on Tuesday said it would meet its 2014 sales and earnings goals already this year as it unveiled a sharp jump in first-quarter...
Read More
category
companyNews
from
Reuters: Company News
Short Interest in Vertex Rises, in Celgene Falls
May 11, 2013
The short interest moves in biotech and emerging pharmaceutical companies were mixed in the latter two weeks of April. The number of shares sold short in Dendreon (NASDAQ: DNDN ), Gilead Sciences...
Read More
category
Regeneron Pharmaceuticals
,
amgen
,
Benzinga
, and 35 more.
from
Latest Articles from Benzinga.com
Merck hit with $100 million discrimination suit
May 10, 2013
category
Health Care
,
Legal Services
,
Merck& Co/
, and 3 more.
from
Business Journals
Gardasil Is Good
May 10, 2013
Crowdsourcing of medical decisions seems to be more and more common. Spend even a little time on twitter or facebook and you will see people posing medical questions to "the crowd". Since crowdsourcing...
Read More
category
NYSE:MRK
from
Forbes Real Time
Merck & Co., Inc Becomes #21 Most Shorted Dow Stock, Replacing Travelers Companies Inc
May 10, 2013
The most recent short interest data has been released by the NASDAQ for the 04/30/2013 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying...
Read More
category
Stocks
from
Market News Video
The FDA Approval Of Merck's Cholesterol Lowerer, Liptruzet, Doesn't Help Its Credibility
May 10, 2013
Josh Bloom recently wrote a very provocative piece entitled: “How can Merck look itself in the mirror?” Bloom is concerned that this once greatly admired pharmaceutical company has lost its way by...
Read More
category
NYSE:MRK
,
NYSE:PFE
from
Forbes Real Time
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here